Our Capabilities
Support your decisions with analytical rigor and custom insights
Corporate Strategy and
Franchise Planning
In both steady and tumultuous times, it’s critical for any organization to establish a clear strategic plan for growth and investment.
Kx Advisors works with executive teams responsible for developing and managing these strategies at the company and franchise level. We do this by objectively and quantitatively assessing the business’s current growth trajectory based on assets both in market and in development.
We then identify and prioritize organic and inorganic opportunities to develop long-term strategies for success—whether seeking to establish an innovative new offering, reinvigorate a mature business, or mitigate impending threats.
Example projects may include:
Portfolio assessment and prioritization
Franchise plan development
Market entry strategy
Market and competitive landscape assessments
Acquisition target identification and screening
M&A and licensing due diligence
Wargaming and scenario planning
Case Study
See how Kx Advisors helped a top 10 pharma company develop a 10-year investment plan to maintain market leadership
Market Expansion and
Forecasting
One of the most powerful advantages a company can have is capturing new growth opportunities within existing markets.
Market expansion for medical technologies can be driven by many factors in healthcare—new sites of service, new healthcare provider groups, expanding market access, and new addressable patient populations.
Kx Advisors thrives in helping clients identify and quantify the business potential for these emerging market trends, and build strategies to seize these opportunities ahead of the competition.
Example projects may include:
Customer white space and adjacency strategies
Market opportunity assessments
Channel strategy optimization
New sites-of-service strategies
Target patient population expansion
Case Study
See how Kx Advisors helped a fortune 500 medical device company reverse a market share loss by developing a strategy for a high-growth site of service
Mergers and
Acquisitions (M&A)
Maintaining a flow of deals and intellectual property (IP) exchange is a core competency for nearly every medical technology company. Kx supports all facets of business development and licensing (BD&L) activities with a flexible and quick-turn approach to deliver highly validated market-level insights to our client’s deal teams.
Example projects may include:
Commercial due diligence
Acquisition target identification and prioritization
Market opportunity assessments
Revenue and profit and loss forecasts
Valuation model development
M&A transaction support
Business case and deal roadmap development
Case Study
See how Kx Advisors helped a mid-cap pharma client successfully identify a highly innovative product and close an exclusive global licensing deal to bolster its pipeline and market capitalization
New Product
Planning
Bringing a new product to market begins with a foundation of detailed planning and analysis often years in advance of launch.
Kx Advisors’ new product planning capabilities enable our clients to better understand market dynamics, areas of differentiation, and strategic tradeoffs to optimize a product’s profile and adoption.
We offer tailored solutions at all stages of product development to support the depth of analysis required for key strategic decisions to unlock value.
Example projects may include:
Product forecasting
Target product profile optimization
Value proposition development
Indication and market prioritization
Patient journey mapping
Customer segmentation and targeting
Competitive intelligence and share capture
Product positioning and testing
Pricing and reimbursement analysis
Case Study
See how Kx Advisors supported the launch of a new drug with a novel mechanism of action by identifying potential product profile improvements to better match market needs, and building a business case to prioritize future clinical investment.
Pricing and
Market Access
In both reimbursed and cash-pay markets, pricing alone can make or break the lifetime value of a product or service.
With the paradigm shift towards value-based care and fee-for-value reimbursement, the need for thoughtful and innovative pricing and market access strategies is paramount.
Kx Advisors’ capabilities enable our clients to leverage pricing as a tool to maximize the inherent value of their portfolios, to anticipate and adapt to competitive pricing dynamics, and to better understand and contextualize global market access structures.
Example projects may include:
Drug and device pricing strategy development
Procedural economic modeling for medical devices
International reference drug pricing analyses
Payer policy and coverage quality strategies
Capital equipment and consumables pricing
Gross-to-net discount optimization
Business model development for software and services
Case Study
See how Kx Advisors determined a franchise-optimized unit price point for a clinical-stage biotech company’s multiple-indication asset to maximize long-range cumulative net income
Brand Planning and
Launch Strategy
Successfully creating and launching new brands is a crucial driver of growth, yet it’s common for new products to fall short of forecasted expectations. In a healthcare environment where there’s often too much information, standing out amongst a crowd and remaining top of mind continues to challenge new brands.
As products in the pipeline move from clinical development to marketing, translating a product profile and clinical data into positioning, tactics, and sales execution requires detailed cross-functional planning.
Kx Advisors helps companies establish differentiated brands — advising on strategies for brand positioning and messaging, targeting, promotion mix, sales operations, and launch monitoring to ensure rapid adoption.
Example projects may include:
Brand positioning and messaging
Marketing investment and mix planning
Launch readiness and monitoring
Commercial operations strategy and benchmarking
Customer segmentation and targeting
Wargaming and scenario planning
Case Study
See how Kx Advisors helped a client develop a holistic launch strategy for a product to maximize adoption, ensure efficient deployment of capital, and proactively monitor launch KPIs for early intervention